John Roboz

2.4k total citations
85 papers, 1.8k citations indexed

About

John Roboz is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, John Roboz has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 25 papers in Spectroscopy and 14 papers in Oncology. Recurrent topics in John Roboz's work include Mass Spectrometry Techniques and Applications (24 papers), Analytical Chemistry and Chromatography (11 papers) and Pharmacogenetics and Drug Metabolism (6 papers). John Roboz is often cited by papers focused on Mass Spectrometry Techniques and Applications (24 papers), Analytical Chemistry and Chromatography (11 papers) and Pharmacogenetics and Drug Metabolism (6 papers). John Roboz collaborates with scholars based in United States, Australia and United Kingdom. John Roboz's co-authors include James F. Holland, Ferenc Hutterer, J. George Bekesi, Hans Pópper, P. Czygan, Fenton Schaffner, D Trülzsch, Helmut Greim, John Greaves and S. V. Thiruvikraman and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Analytical Chemistry.

In The Last Decade

John Roboz

81 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Roboz United States 23 507 366 305 233 199 85 1.8k
Leo Stolk Netherlands 23 468 0.9× 249 0.7× 88 0.3× 202 0.9× 216 1.1× 68 2.4k
John M. Strong United States 30 661 1.3× 580 1.6× 249 0.8× 85 0.4× 130 0.7× 76 2.4k
Mark J. Rose United States 23 794 1.6× 334 0.9× 292 1.0× 86 0.4× 86 0.4× 49 2.7k
Fábio C. Tucci United States 29 529 1.0× 252 0.7× 283 0.9× 242 1.0× 186 0.9× 101 2.6k
Daniel S. Zaharko United States 27 1.0k 2.0× 552 1.5× 101 0.3× 101 0.4× 101 0.5× 64 2.7k
M. J. X. Hillebrand Netherlands 31 769 1.5× 812 2.2× 173 0.6× 186 0.8× 288 1.4× 77 2.6k
Jerry M. Rice United States 33 1.4k 2.7× 689 1.9× 200 0.7× 160 0.7× 88 0.4× 124 3.8k
Ronney A. De Abreu Netherlands 35 1.7k 3.3× 809 2.2× 76 0.2× 348 1.5× 294 1.5× 137 3.8k
Charles L. Litterst United States 27 731 1.4× 908 2.5× 77 0.3× 118 0.5× 173 0.9× 71 2.6k
E. Weidekamm Switzerland 25 587 1.2× 1.3k 3.5× 125 0.4× 405 1.7× 428 2.2× 61 2.8k

Countries citing papers authored by John Roboz

Since Specialization
Citations

This map shows the geographic impact of John Roboz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Roboz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Roboz more than expected).

Fields of papers citing papers by John Roboz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Roboz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Roboz. The network helps show where John Roboz may publish in the future.

Co-authorship network of co-authors of John Roboz

This figure shows the co-authorship network connecting the top 25 collaborators of John Roboz. A scholar is included among the top collaborators of John Roboz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Roboz. John Roboz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammer, Peter L., et al.. (2017). A Classification Model to Predict the Rate of Decline of Kidney Function. Frontiers in Medicine. 4. 97–97. 5 indexed citations
2.
Roboz, John & Gail J. Roboz. (2015). Mass spectrometry in leukemia research and treatment. Expert Review of Hematology. 8(2). 225–235. 5 indexed citations
3.
Wang, Xiaoli, et al.. (2014). C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients. Experimental Hematology. 43(2). 100–109.e1. 27 indexed citations
4.
Cosenza, Stephen C., et al.. (2012). Determination of the glucuronide metabolite of ON 013100, a benzylstyrylsulfone antineoplastic drug, in colon cancer cells using LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 75. 138–144. 2 indexed citations
5.
Xu, Mingjiang, et al.. (2010). The Effect of CXCL12 Processing on CD34+ Cell Migration in Myeloproliferative Neoplasms. Cancer Research. 70(8). 3402–3410. 55 indexed citations
6.
Ohnuma, Takao, et al.. (2010). Discontinuous Drug Binding to Proteins: Binding of an Antineoplastic Benzyl Styryl Sulfone to Albumin and Enzymes In Vitro and in Phase I Clinical Trials. Drug Metabolism and Disposition. 38(9). 1480–1485. 3 indexed citations
7.
Roboz, John. (2005). Mass Spectrometry in Diagnostic Oncoproteomics. Cancer Investigation. 23(5). 465–478. 12 indexed citations
8.
Lehrer, Steven, John Roboz, Hu Ding, et al.. (2003). Putative protein markers in the sera of men with prostatic neoplasms. British Journal of Urology. 92(3). 223–225. 49 indexed citations
9.
Roboz, John, et al.. (1998). Investigation of suramin-albumin binding by electrospray mass spectrometry. Rapid Communications in Mass Spectrometry. 12(19). 1319–1322. 5 indexed citations
10.
Roboz, John, Jian Jiang, J F Holland, & J. George Bekesi. (1997). Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.. PubMed. 57(21). 4795–802. 9 indexed citations
11.
Roboz, John, et al.. (1996). Acidic coupling and aminolytic TFA cleavage approaches in a new synthesis of an l- m-sarcolysin containing antitumor tripeptide ester. Tetrahedron Letters. 37(5). 563–566. 11 indexed citations
12.
13.
Roboz, John. (1994). Diagnosis and monitoring of disseminated candidiasis based on serum/urine D/L‐arabinitol ratios. Chirality. 6(2). 51–57. 10 indexed citations
14.
15.
Roboz, John, et al.. (1987). Role of individual serum pentitol concentrations in the diagnosis of disseminated visceral candidiasis. European Journal of Clinical Microbiology & Infectious Diseases. 6(6). 708–714. 15 indexed citations
16.
Roboz, John, Jennifer Greaves, & J. George Bekesi. (1985). Polybrominated biphenyls in model and environmentally contaminated human blood: protein binding and immunotoxicological studies.. Environmental Health Perspectives. 60. 107–113. 10 indexed citations
17.
Roboz, John, et al.. (1980). Mass spectrometric technique for the determination of N-phosphonoacetyl-l-aspartic acid in serum. Journal of Chromatography B Biomedical Sciences and Applications. 181(2). 195–205. 2 indexed citations
18.
Ohnuma, Takao, et al.. (1977). Pharmacological and biochemical effects of pyrazofurin in humans.. PubMed. 37(7 Pt 1). 2043–9. 20 indexed citations
19.
Roboz, John, et al.. (1977). Preclinical toxicological study of phosphonoacetic acid: Determination in blood by selected ion monitoring. Journal of Mass Spectrometry. 4(5). 291–296. 4 indexed citations
20.
Roboz, John. (1975). Mass Spectrometry in Clinical Chemistry. Advances in clinical chemistry. 17. 109–191. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leo Stolk Breakdown of academic impact, for papers by John M. Strong Breakdown of academic impact, for papers by Mark J. Rose Breakdown of academic impact, for papers by Fábio C. Tucci Breakdown of academic impact, for papers by Daniel S. Zaharko Breakdown of academic impact, for papers by M. J. X. Hillebrand Breakdown of academic impact, for papers by Jerry M. Rice Breakdown of academic impact, for papers by Ronney A. De Abreu Breakdown of academic impact, for papers by Charles L. Litterst Breakdown of academic impact, for papers by E. Weidekamm
Rankless by CCL
2026